Covid-19 scenario:
- The Covid-19 pandemic disrupted workflows in the healthcare sector across the globe. The spread of virus forced several industries to shutdown temporarily or permanently. This disrupted the supply chain.
- However, the pandemic has a positive effect on the market as it increased the demand for various medical services such as oligonucleotide products for developing test kits, vaccines, and treatments that target Covid-19 infection.
- Moreover, due to the rise in Covid-19 cases and the urgency for a potential vaccine, the demand for new generations of oligonucleotide drugs, such as mRNA and DNA vaccines has increased.
According to the report published by Allied Market Research, The Oligonucleotide Synthesis Market Size was valued at USD 5.19 billion in 2020, and it is estimated to surpass around USD 26.09 billion by 2030, with a registered CAGR of 17.1% from 2021 to 2030.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.alliedmarketresearch.com/request-sample/8721
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in the coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
• How big is the global & regional market in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• Which region has more opportunities?
Global Oligonucleotide Synthesis Market Segmentation –
By Product, the synthesized oligonucleotides segment is estimated to portray the highest CAGR of 18.1% during the forecast period, due to rise in use of synthesized oligonucleotides in several streams including molecular diagnosis and clinical application. However, the oligonucleotide-based drugs segment held the largest share in 2020, accounting for more than one-third of the global oligonucleotide synthesis market, owing to rise in number of FDA-approved drugs and clinical pipeline of oligonucleotide-based drugs.
By Application, the therapeutic segment held the largest share in 2020, contributing to around two-fifths of the global oligonucleotide synthesis market, owing to the rise in research of therapeutic application. However, the research segment is projected to manifest the highest CAGR of 17.6% during the forecast period, owing to rise in approval of several drugs over the last few years.
By Region, the global oligonucleotide synthesis market across North America held the largest share in 2020, accounting for more than one-third of the market. This is due to rise in R&D in life sciences, surge in focus on improving the safety & quality of healthcare, increase in demand for high-quality research tools for data reproducibility, and surge in focus on developing personalized therapeutics.
However, the market across Asia-Pacific is expected to register the highest CAGR of 18.8% during the forecast period, owing to expanding healthcare infrastructure, surge in government support and investment, and economic development in the region.
Oligonucleotide Synthesis Companies: –
- Alnylam Pharmaceuticals, Inc.
- Danaher Corporation
- Biogen Inc.
- Ionis Pharmaceuticals, Inc.
- Eurofins Scientific
- LGC Limited
- Kaneka Corporation
- Sarepta Therapeutics, Inc.
- Merck KGAA
- Thermo Fisher Scientific, Inc.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/8721
By Region Outlook
North America
⦁ U.S.
⦁ Canada
⦁ Mexico
Europe
⦁ UK
⦁ Germany
⦁ France
⦁ Italy
⦁ Russia
⦁ Rest of Europe
Asia-Pacific
⦁ China
⦁ Japan
⦁ India
⦁ Australia
⦁ Rest of Asia-Pacific
LAMEA
⦁ Brazil
⦁ UAE
⦁ Turkey
⦁ Saudi Arabia
⦁ Rest of LAMEA
Have Any Query? Ask Our Experts: https://www.alliedmarketresearch.com/connect-to-analyst/8721
Other Trending Report:
- Healthcare IT Market
- Rheumatoid Arthritis Drugs Market
- Allergy Diagnostics Market
- Medical Device Affairs Outsourcing Market
- Medical Tape market
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.